Indoco Remedies Limited
INDOCO.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.88B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.88 Billion |
|---|---|
| Enterprise Value | $20.88 Billion |
| Annual dividend | $0.20 |
| Dividend yield | 0.09% |
| Earnings per Share | $-10.7 |
| Beta | 0.64 |
| Outstanding Shares | 91,664,316 |
Return
| Return on Equity | 0.39% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 781.03 |
|---|---|
| PEG | -277.37 |
| Price to Sales | 1.04 |
| Price to Book Ratio | 2.07 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | 15.19 |
| Enterprise Value to Net Income | 581 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
$-0.83
Consensus analyst estimateRevenue Estimate
$5.07 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.25
Consensus analyst estimateRevenue Estimate
$4.97 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Indoco Remedies Limited
6,000 employees
CEO: Aditi Kare Panandikar
Indoco Remedies Limited, headquartered in Mumbai, India, is a diversified pharmaceutical company founded in 1945 (formerly Indo Continental Trading Company). The company specializes in the development, manufacturing, marketing, and globa...